Virginia National Bankshares Corp
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
VABK$53.37+1.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders’ Equity (unaudited)
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025
| Common Stock | Capital Surplus | Retained Earnings | Accumulated Other Comprehensive Loss | Total | |
|---|---|---|---|---|---|
| Balance, December 31, 2024 | $13,263 | $106,394 | $82,507 | $(41,862) | $160,302 |
| Stock option expense | - | 34 | - | - | 34 |
| Restricted stock grant expense | - | 214 | - | - | 214 |
| Vested stock grants | 33 | (33) | - | - | - |
| Cash dividends declared ($0.33 per share) | - | - | (1,779) | - | (1,779) |
| Net income | - | - | 4,489 | - | 4,489 |
| Other comprehensive income | - | - | - | 3,521 | 3,521 |
| Balance, March 31, 2025 | $13,296 | $106,609 | $85,217 | $(38,341) | $166,781 |
| Stock option expense | - | 35 | - | - | 35 |
| Restricted stock grant expense | - | 212 | - | - | 212 |
| Vested stock grants | 22 | (22) | - | - | - |
| Cash dividends declared ($0.36 per share) | - | - | (1,941) | - | (1,941) |
| Net income | - | - | 4,238 | - | 4,238 |
| Other comprehensive income | - | - | - | 1,447 | 1,447 |
| Balance, June 30, 2025 | $13,318 | $106,834 | $87,514 | $(36,894) | $170,772 |
| Balance, December 31, 2025 | $13,327 | $107,337 | $94,165 | $(30,668) | $184,161 |
| Shares surrendered in connection with stock option exercise | (42) | (630) | - | - | (672) |
| Stock options exercised | 63 | 609 | - | - | 672 |
| Stock option expense | - | 4 | - | - | 4 |
| Restricted stock grant expense | - | 298 | - | - | 298 |
| Vested stock grants | 45 | (45) | - | - | - |
| Cash dividends declared ($0.36 per share) | - | - | (1,949) | - | (1,949) |
| Net income | - | - | 5,259 | - | 5,259 |
| Other comprehensive loss | - | - | - | (1,276) | (1,276) |
| Balance, March 31, 2026 | $13,393 | $107,573 | $97,475 | $(31,944) | $186,497 |
| Shares surrendered in connection with stock option exercise | (27) | (552) | - | - | (579) |
| Stock options exercised | 32 | 547 | - | - | 579 |
| Stock option expense | - | 23 | - | - | 23 |
| Restricted stock grant expense | - | 208 | - | - | 208 |
| Vested stock grants | 18 | (18) | - | - | - |
| Cash dividends declared ($0.36 per share) | - | - | (1,952) | - | (1,952) |
| Net income | - | - | 9,008 | - | 9,008 |
| Other comprehensive income | - | - | - | 901 | 901 |
| Balance, June 30, 2026 | $13,416 | $107,781 | $104,531 | $(31,043) | $194,685 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.